HRT Financial’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36M Buy
+250,000
New +$1.4M ﹤0.01% 1864
2023
Q2
Sell
-24,600
Closed -$637K 3263
2023
Q1
$637K Sell
24,600
-33,000
-57% -$883K 0.01% 1209
2022
Q4
$1.36M Buy
57,600
+30,500
+113% +$822K 0.02% 763
2022
Q3
$686K Sell
27,100
-2,100
-7% -$73.7K 0.01% 1248
2022
Q2
$969K Buy
29,200
+11,700
+67% +$497K 0.01% 979
2022
Q1
$1.26M Sell
17,500
-17,600
-50% -$1.27M 0.01% 873
2021
Q4
$3.22M Buy
+35,100
New +$4.2M 0.02% 437

Other funds holding TDOC

HRT Financial's TDOC Position: Q4 2025 in Review

HRT Financial sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 178,419 shares — an estimated $1.38M sold.

HRT Financial first reported a position in TDOC in Q3 2018 and held it in 12 quarters. The position peaked at $26.9M in Q2 2020. 345 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • HRT Financial reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 178,419 Teladoc Health shares in Q4 2025, an estimated $1.38M.
  • HRT Financial first reported a position in Teladoc Health in Q3 2018 and held it in 12 quarters.
  • HRT Financial's Teladoc Health position peaked at $26.9M in Q2 2020.
  • 345 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.